These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma]. Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292 [TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003 [TBL] [Abstract][Full Text] [Related]
12. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion. Sidda A; Naleid NK; Manu G; Graffeo V; Jamil MO J Investig Med High Impact Case Rep; 2022; 10():23247096221111767. PubMed ID: 35861500 [TBL] [Abstract][Full Text] [Related]
13. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant. Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392 [TBL] [Abstract][Full Text] [Related]
15. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases. Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195 [TBL] [Abstract][Full Text] [Related]
16. Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment. Eichenauer DA; Hartmann S Expert Rev Hematol; 2023; 16(8):607-615. PubMed ID: 37337881 [TBL] [Abstract][Full Text] [Related]
17. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications. Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651 [TBL] [Abstract][Full Text] [Related]
18. Modern management of lymphocyte-predominant Hodgkin lymphoma. Xing KH; Savage KJ Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605 [TBL] [Abstract][Full Text] [Related]
19. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only. van Grotel M; Lam KH; de Man R; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260 [TBL] [Abstract][Full Text] [Related]
20. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma. Nogová L; Rudiger T; Engert A Hematology Am Soc Hematol Educ Program; 2006; ():266-72. PubMed ID: 17124071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]